期刊文献+

TRAIL联合氟尿嘧啶体外诱导结肠癌细胞凋亡

Apoptosis of human colon cancer cells induced by TRAIL combination with fluorouvacil in vitro
暂未订购
导出
摘要 目的:探讨氟尿嘧啶(Fu)对重组人肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor-relatedapoptosis-inducing ligand,TRAIL)诱导结肠癌细胞凋亡的影响及其作用机制。方法:采用四甲基偶氮唑蓝比色法检测Fu及联合rmhTRAIL对人结肠癌SW480的IC50值;流式细胞术检测不同浓度Fu与rmhTRAIL联合处理SW480 24 h后细胞的凋亡率;实时荧光定量PCR和Western印迹法检测不同浓度Fu与rmhTRAIL联合处理SW480 24 h后细胞survivin基因mRNA和蛋白表达变化。结果:细胞经药物处理24 h后,单用组IC50值为29.5μmol/L,Fu联合rmhTRAIL组IC50值为6.4μmol/L,高质量浓度联合组药物相互作用系数为0.92;Fu与rmhTRAIL联合作用24 h后,随Fu质量浓度增高survivin mRNA和蛋白的表达显著下调。结论:Fu能增强TRAIL诱导的结肠癌细胞凋亡,其机制可能与下调survivin表达有关。 Objective: To investigate the effect of fluorouvacil (Fu) on recombinant human tumor necrosis factor- related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human colon cancer cells and the underlying mechanisms. Methods: The effect of Fu combined with rmhTRAIL on human colon cancer SW480 cell line was detected by M'IT assay and ICS0 was calculated. The apoptotic rate after treatment for 24 h was detected by flow cytometry, survivin mRNA and protein level in SW480 cells was examined by real time-PCR and Western blot 24 h before or after treatments. Results: The IC50 for Fu treatment alone or Fu combined with rmhTRAIL was 29.5 8mol/L or 6.4 μmol/L, respectivelF The coefficient of drug in interaction in the high dosage group was 0.92. Compared with Fu or rmhTRAIL alone, the combination of Fu and rmhTRAIL could increase the apoptotic ratio significantly (P〈0.05). Real time-PCR and Western blot showed that the expression of survivin in the combined group was obviously less than that in the group of Fu or rmhTRAIL alone. Conclusion: Fu promotes TRAIL- induced apoptosis in human colon cancer cells, which is likely involved in the down-regulation of survivin expression.
出处 《国际病理科学与临床杂志》 CAS 2012年第6期469-472,共4页 Journal of International Pathology and Clinical Medicine
基金 衡阳市科技局课题(2010KS35)~~
关键词 氟尿嘧啶 肿瘤坏死因子相关凋亡诱导配体 结肠癌 凋亡 survivin fluorouvacil tumor necrosis factor-related apoptosis-inducing ligand human colon cancer apoptosis survivin
  • 相关文献

参考文献13

  • 1Thanaketpaisarn O, Waiwut P, Sakurai H, et al. Artesunateenhances TRAIL-induced apoptosis in human cervicalcarcinoma cells through inhibition of the NF-kB and PI3K/Akt signaling pathways [J]. Int J Oncol, 2011, 39(1):279-285.
  • 2Abdulghani J, EJ-Deiry WS. TRAIL receptor signalingand therapeutics [J]. Expert Opin Ther Targets, 2010,14(10):1091-1108.
  • 3Khaider NG, Lane D, Matte I, et al. Targeted ovarian cancertreatment: the TRAILs of resistance [J]. Am J Cancer Res,2012, 2(1):75-92.
  • 4Moon DO, Kang CH, Kang SH; et al. Capsaicin sensitizesTRAIL-induced apoptosis through Spl-mediated DR5 upregulation: involvement of Ca2+ influx [J]. Toxieol ApplPharmacol, 2012, 259(1):87-95.
  • 5廖前进,周钰娟.TRAIL诱导结肠癌SW480细胞的凋亡[J].南华大学学报(医学版),2010,38(5):617-619. 被引量:3
  • 6赵雪强,王绩英,王昌明,莫碧文,蒋明,陈峰.三氧化二砷增强TRAIL杀伤人A549细胞的作用及机制研究[J].中国药理学通报,2011,27(3):415-418. 被引量:9
  • 7Szliszka E, Jaworska D, Ksek M, et al. Targeting death receptorTRAIL-R2 by chalcones for TRAIL-induced apoptosis incancer cells [J]. IntJ Mol Sci, 2012, 13(11):15343-15359.
  • 8林英健,齐玲芝,于燕.凋亡抑制基因Survivin在胃癌中的表达及临床分析[J].中国老年学杂志,2011,31(9):1654-1655. 被引量:7
  • 9Yang CT, Li JM, Weng HH, et al. Adenovirus-mediated transferof siRNA against survivin enhances the radiosensitivity ofhuman non-small cell lung cancer cells [J]. Cancer Gene Ther,2010,17(2):120-130.
  • 10Kim JY, Kim EH, Kim SU, et al. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR$ upregulation and survivin downregulation [J]. Carcinogenesis, 2010, 31(3):367-375.

二级参考文献20

  • 1张莉,王玲,宋维华,温薇,孙宏丽,吴兆菊,杨宝峰.三氧化二砷通过升高细胞内钙离子浓度介导肺癌细胞凋亡[J].中国药理学通报,2004,20(8):867-870. 被引量:19
  • 2冯觉平,孔庆志,黄涛,成静,李敏,王亚萍.三氧化二砷对肺腺癌耐药细胞A549/R耐药性的影响[J].中华实验外科杂志,2006,23(2):201-203. 被引量:19
  • 3Wiley SR, Schooley K, Stoolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis [ J ]. Immunity, 1995, 3 (6) : 673 - 382.
  • 4Trisha Gura. How TRAIL kills cancer cells, but not normal cells[J]. Science, 1997, 277(5327) :768.
  • 5Buchsbaun D J, Zhou T, Idbuguo AF. TRAIL receptor- targeted therapy[J]. Future Oncol, 2006, 2(4): 493- 508.
  • 6SchaeferU, Voloshanenko O, WilienD, et al. rrRAIL: amultifunctional cytokihe [ J ]. Front Piosci, 2007, 12 : 3813 - 3824.
  • 7CretneyE, Takeda K, Smyth MJ. Cancer:noveltherapeutic strategiesthat exploit the TNF related apoptosis - indudng ligand (TRAIL)/TRAI1 receptor pathway [ J ]. Int J Biochem Cell Piol, 2007, 39 (2) : 280 - 286.
  • 8Wu GS. TRAIL as a target in anti -cancer therapy [ J ]. Cancer Lett, 2009, 285 ( 1 ) : 1 - 5.
  • 9Yang E, Korsmeyer SJ. Molecular thonatopsis:a discourse on the Bcl -2 family and cell death[J]. Blood, 1996,88 : 386 -401.
  • 10Nencioni A, Wile L, Dal Bello G, et al. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor related apoptosis - inducing ligand in chemoresistant Bcl- 2 -overexpressing cells [ J ]. Clin Cancer Res, 2005, 11:4259 -4265.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部